VYGR (STOCKS)
Voyager Therapeutics, Inc. Common Stock
$3.640000
+0.140000 (+4.00%)
Prev close: $3.500000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Alfred W. Sandrock
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $219.93M
- Employees
- 172
- P/E (TTM)
- -1.84
- P/B (TTM)
- 1.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.47 | $-0.56 | +0.0922 | +16.40% |
|
Dec 2025 (Q4)
|
$-0.46 | $-0.52 | +0.0607 | +11.66% |
|
Sep 2025 (Q3)
|
$-0.47 | $-0.53 | +0.0608 | +11.45% |
|
Jun 2025 (Q2)
|
$-0.57 | $-0.54 | -0.0339 | -6.32% |
Financial Statements
| Revenues | $36.49M |
| Benefits Costs and Expenses | $153.01M |
| Costs And Expenses | $153.01M |
| Nonoperating Income/Loss | $10.91M |
| Operating Expenses | $163.92M |
| Research and Development | $127.75M |
| Other Operating Expenses | $36.17M |
| Operating Income/Loss | -$127.42M |
| Income/Loss From Continuing Operations After Tax | -$116.64M |
| Income/Loss From Continuing Operations Before Tax | -$116.52M |
| Income Tax Expense/Benefit | $121.00K |
| Net Income/Loss | -$116.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$116.64M |
| Net Income/Loss Available To Common Stockholders, Basic | -$116.64M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.98 |
| Diluted Earnings Per Share | -$1.98 |
| Basic Average Shares | 177,048,865 |
| Diluted Average Shares | 177,048,865 |
| Assets | $219.33M |
| Current Assets | $146.98M |
| Cash | $171.70M |
| Accounts Receivable | $1.49M |
| Noncurrent Assets | $72.34M |
| Fixed Assets | $12.22M |
| Other Non-current Assets | $60.13M |
| Liabilities | $45.66M |
| Current Liabilities | $17.45M |
| Accounts Payable | $2.72M |
| Wages | $3.31M |
| Other Current Liabilities | $11.42M |
| Noncurrent Liabilities | $28.20M |
| Equity | $173.67M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $173.67M |
| Liabilities And Equity | $219.33M |
| Net Cash Flow From Operating Activities | -$127.99M |
| Net Cash Flow From Operating Activities, Continuing | -$127.99M |
| Net Cash Flow From Investing Activities | $92.35M |
| Net Cash Flow From Investing Activities, Continuing | $92.35M |
| Net Cash Flow From Financing Activities | $4.07M |
| Net Cash Flow From Financing Activities, Continuing | $4.07M |
| Net Cash Flow | -$31.58M |
| Net Cash Flow, Continuing | -$31.58M |
| Comprehensive Income/Loss | -$116.68M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$116.70M |
| Other Comprehensive Income/Loss | -$27.93M |
| Other Comprehensive Income/Loss Attributable To Parent | -$64.00K |